文献速递消化道肿瘤与早癌

突变CEACAM蛋白破坏TGFB信号并改变肠道菌群促进结直肠癌发生

Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
PubMed 文献 · Gastroenterology · 2019-10-01

研究分析结直肠腺癌中CEACAM家族与TGFB信号通路的相互作用。456例和594例TCGA数据揭示CEACAM高表达与生存期缩短相关,且与TGFB通路基因表达呈负相关。发现CEACAM5功能获得性突变可抑制TGFB信号并增强细胞增殖,TGFB信号缺陷小鼠肠道菌群促癌菌增加。

要点

  • CEACAM基因高表达与结直肠腺癌患者生存期缩短相关
  • CEACAM5突变(L640I、A643T)增强非锚定依赖生长并抑制TGFB信号
  • TGFB信号缺陷小鼠肠道促癌菌增加、有益菌减少

核心结论

  • CEACAM蛋白通过破坏TGFB信号改变肠道菌群组成,促进结直肠癌发生。
  • 结直肠腺癌中CEACAM5突变具有功能获得性,增强增殖并抑制TGFB信号。

研究设计与样本

  • 研究分析TCGA中456例结直肠腺癌的DNA序列、mRNA表达和生存数据,以及另一组594例结直肠腺癌样本。
  • 对野生型小鼠和TGFB信号缺陷小鼠(Sptbn1+/-和Smad4+/-/Sptbn1+/-)粪便进行宏基因组测序。
  • 在SW480和HCT116结直肠癌细胞系中过表达CEACAM蛋白及其突变体,进行免疫印迹、增殖和集落形成实验。

主要发现

  • 结直肠腺癌中CEACAM基因(尤其CEACAM5)高表达与患者生存期缩短相关。
  • CEACAM基因表达与TGFB通路基因(TGFBR1、TGFBR2、SMAD3)表达呈负相关。
  • 结直肠腺癌中存在CEACAM5 B3结构域L640I和A643T突变,结构研究提示这些突变改变CEACAM5与TGFBR1的相互作用。
  • 过表达CEACAM5突变体较野生型更增强SW480和HCT116细胞的非锚定依赖生长并更抑制TGFB信号,提示功能获得性突变。
  • TGFB信号缺陷小鼠粪便中促结肠肿瘤菌(如Clostridium septicum)增多,有益菌(如Bacteroides vulgatus和Parabacteroides distasonis)减少。

临床怎么用

  • CEACAM5高表达或突变可作为结直肠腺癌预后评估的潜在生物标志物。
  • 靶向CEACAM5-TGFB信号轴或调节肠道菌群可能成为结直肠癌防治策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We studied interactions among proteins of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family, which interact with microbes, and transforming growth factor beta (TGFB) signaling pathway, which is often altered in colorectal cancer cells. We investigated mechanisms by which CEACAM proteins inhibit TGFB signaling and alter the intestinal microbiome to promote colorectal carcinogenesis. METHODS: We collected data on DNA sequences, messenger RNA expression levels, and patient survival times from 456 colorectal adenocarcinoma cases, and a separate set of 594 samples of colorectal adenocarcinomas, in The Cancer Genome Atlas. We performed shotgun metagenomic sequencing analyses of feces from wild-type mice and mice with defects in TGFB signaling (Sptbn1+/- and Smad4+/-/Sptbn1+/-) to identify changes in microbiota composition before development of colon tumors. CEACAM protein and its mutants were overexpressed in SW480 and HCT116 colorectal cancer cell lines, which were analyzed by immunoblotting and proliferation and colony formation assays. RESULTS: In colorectal adenocarcinomas, high expression levels of genes encoding CEACAM proteins, especially CEACAM5, were associated with reduced survival times of patients. There was an inverse correlation between expression of CEACAM genes and expression of TGFB pathway genes (TGFBR1, TGFBR2, and SMAD3). In colorectal adenocarcinomas, we also found an inverse correlation between expression of genes in the TGFB signaling pathway and genes that regulate stem cell features of cells. We found mutations encoding L640I and A643T in the B3 domain of human CEACAM5 in colorectal adenocarcinomas; structural studies indicated that these mutations would alter the interaction between CEACAM5 and TGFBR1. Overexpression of these mutants in SW480 and HCT116 colorectal cancer cell lines increased their anchorage-independent growth and inhibited TGFB signaling to a greater extent than overexpression of wild-type CEACAM5, indicating that they are gain-of-function mutations. Compared with feces from wild-type mice, feces from mice with defects in TGFB signaling had increased abundance of bacterial species that have been associated with the development of colon tumors, including Clostridium septicum, and decreased amounts of beneficial bacteria, such as Bacteroides vulgatus and Parabacteroides distasonis. CONCLUSION: We found expression of CEACAMs and genes that regulate stem cell features of cells to be increased in colorectal adenocarcinomas and inversely correlated with expression of TGFB pathway genes. We found colorectal adenocarcinomas to express mutant forms of CEACAM5 that inhibit TGFB signaling and increase proliferation and colony formation. We propose that CEACAM proteins disrupt TGFB signaling, which alters the composition of the intestinal microbiome to promote colorectal carcinogenesis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Gu S, Zaidi S, Hassan MI, et al. Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology. 2019. PMID: 31585122. doi:10.1053/j.gastro.2019.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。